A recent study indicates that an AI tool can analyze routine mammogram scans for breast cancer screening and predict heart disease risk in women.
What you need to know The prevalence of heart failure across Europe is estimated to be 1-2% of adults.1 In the UK, this places a substantial burden on patients and healthcare resources, including ...
Want to give your heart a little TLC? Across the country, nearly half of all adults have some form of cardiovascular disease, the leading cause of death for American men and women. With numbers like ...
The team used AI to analyze the amount of calcium deposit in the arteries of the breast tissue, known to be a risk factor for heart disease.
Prior authorization, a process that requires physicians to obtain approval from health care insurers before certain treatments are covered, may keep patients from filling prescriptions for two ...
A secondary analysis of the SOUL trial shows significant improvement in heart failure outcomes with oral semaglutide vs placebo, consistent with the injectable formulation.
Background Pharmacotherapy combinations have been shown to improve survival and reduce hospitalisations in adults with ...
Poor gut health could increase the risk of dying early or being hospitalized by almost 10% for people with heart failure, and in the first year after being admitted to hospital with heart failure, ...
There was a consensus that more data are needed to answer this question, with discussions about what such a trial would look like.
The risk of serious or fatal heart disease can be predicted with artificial intelligence (AI) analysis of mammograms, according to research published in the European Heart Journal . The ...
Doctors must treat sepsis quickly to prevent organ failure. But demographic change and drug-resistant infections are making the condition harder to manage.
A growing health debate is spilling into America’s coffee cups, as Health and Human Services Secretary Robert F. Kennedy, Jr. questions the amount of sugar in drinks sold by Starbucks and Dunkin’.